Use of Bevacizumab and Ranibizumab for Wet Age-Related Macular Degeneration: Influence of CATT Results and Introduction of Aflibercept

To assess whether publication of Comparison of Age-related macular degeneration Treatment Trial (CATT) results and introduction of aflibercept to the marketplace affected intravitreal bevacizumab and ranibizumab utilization.Design: Retrospective analysis of treatment patterns.

Source: American Journal of Ophthalmology - May 13, 2019 Category: Opthalmology Authors: Suzann Pershing, Nidhi Talwar, Stephen T. Armenti, Joseph Grubbs, Julie M. Rosenthal, Vaidehi S. Dedania, Joshua D. Stein Tags: Original Articles Source Type: research